DPRS to reaffirm the implementation of incentive system in favor of low-priced drugs

Published: 2002-04-26 06:59:00

Updated: 2002-04-26 06:59:00

The Drug Price Review Subcommittee under the Heath Insurance Policy Deliberation Council has recently reaffirmed the government plan to promote the use of low-priced drugs via an incentive system of granting to the medical institutions the drug margin up to 50 percent, in spite of strong oppositi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK